Andrew Oh, MD
Pain Medicine · Portland, ORNPI 1932312766
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Vertiflex, Inc. at 58.3% of the total. Reporting peaked in 2019 at $18,698 and has fallen 89.5% since, to $1,965 in 2025. Among pain medicine clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $96.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$18K
- Abbott$4K
- Spinal Simplicity, LLC$2K
- Si-bone, Inc.$2K
- Boston Scientific$863
- Aurora Spine, Inc.$793
- plus $4K from 29 others
Across 1 payment — averaging $5700.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertiflex, Inc.$6K
What the payments were for
- Speaking & faculty fees$15,50051%
- Travel & lodging$4,32414%
- Food & beverage$8,22127%
- Education$1,6135%
- Entertainment$4451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 13 | $17,560 |
| Abbott | 151 | $3,596 |
| Spinal Simplicity, LLC | 6 | $2,230 |
| Si-bone, Inc. | 14 | $1,528 |
| Boston Scientific | 15 | $863 |
| Aurora Spine, Inc. | 1 | $793 |
| AbbVie(2 entities) | 33 | $640 |
| Relievant Medsystems, Inc. | 8 | $551 |
| VGI Medical, LLC | 1 | $445 |
| Stimwave Technologies Incorporated | 3 | $216 |
| Nalu Medical, Inc. | 4 | $211 |
| Collegium Pharmaceutical, Inc. | 11 | $180 |
| Spinefrontier, Inc. | 3 | $161 |
| Vertos Medical, Inc. | 2 | $152 |
| Amgen | 5 | $111 |
| Pfizer | 7 | $109 |
| GRT US Holding, Inc. | 4 | $86 |
| Biohaven Pharmaceuticals, Inc. | 4 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Bioventus LLC | 2 | $70 |
| Merz Pharmaceuticals, LLC | 2 | $65 |
| Averitas Pharma Inc. | 2 | $62 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Medtronic | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Vertex | 1 | $23 |
| Globus Medical | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Novartis | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Nevro Corp. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$17,187
- HA MINUTEMAN G3-R$2,010
- IFUSE IMPLANT SYSTEM$1,088
- ZIP$793
- Intracept$722
- SiJoin$445
- PROCLAIM$236
- WAVEWRITER ALPHA$225
- Nalu Neurostimulation System$146
- INFINION$138
- InSpan$137
- SacroFuse$137
- NanoFuse Putty$137
- Proclaim Family of SCS IPGs$133
- mild Device Kit$104
How this compares
$30,103 in reported general payments places this provider in the 90th percentile of 57 pain medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $4,700 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 171 | $3,896 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 145 | $3,262 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 38 | $3,125 |
| Buprenorphine Hcl | 90 | $3,061 |
| Oxycodone Hcl | 181 | $2,915 |
| Duloxetine Hcl | 164 | $2,891 |
| Gabapentin | 184 | $2,613 |
| Pregabalin | 118 | $2,015 |
| Morphine Sulfate ErMorphine Sulfate | 73 | $1,912 |
| Tizanidine Hcl | 120 | $1,693 |
| Celecoxib | 36 | $1,440 |
| Cyclobenzaprine Hcl | 55 | $1,113 |
| Fentanyl | 15 | $1,012 |
| Tramadol Hcl ErTramadol Hcl | 12 | $796 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Portland
- Kimberly MauerPortland$59K
- Stuart RosenblumPortland$31K
- Joseph StapletonPortland$13K
- Salman HiraniPortland$5K
- Behnum HabibiPortland$3K
- Sandy ChristiansenPortland$3K
- Ginevra LiptanPortland$2K
- James BertolaPortland$2K
- Robert FoegePortland$2K
- Irvan BubicPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.